In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Concentrix Corp (NASDAQ: CNXC) was $39.18 for the day, down -3.21% from the previous closing price of $40.48. In other words, the price has decreased by -$3.21 from its previous closing price. On the day, 3.63 million shares were traded. CNXC stock price reached its highest trading level at $42.48 during the session, while it also had its lowest trading level at $37.85.
Ratios:
Our analysis of CNXC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.73. For the most recent quarter (mrq), Quick Ratio is recorded 1.56 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 1.69 whereas as Long-Term Debt/Eq ratio is at 1.67.
Upgrades & Downgrades
In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $70.
BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for the stock was revised from $65 to $85.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 28 ’25 when Twomey Cormac J sold 500 shares for $35.50 per share. The transaction valued at 17,750 led to the insider holds 35,130 shares of the business.
CORMAC TWOMEY bought 500 shares of CNXC for $17,750 on Nov 28 ’25. On Oct 31 ’25, another insider, Caldwell Christopher A, who serves as the President and CEO of the company, bought 1,000 shares for $40.00 each. As a result, the insider paid 40,000 and bolstered with 287,661 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 2418934016 and an Enterprise Value of 7916431360. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 0.814 whereas that against EBITDA is 5.742.
Stock Price History:
The Beta on a monthly basis for CNXC is 0.50, which has changed by -0.14725089 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, CNXC has reached a high of $66.00, while it has fallen to a 52-week low of $31.62. The 50-Day Moving Average of the stock is 1.93%, while the 200-Day Moving Average is calculated to be -19.52%.
Shares Statistics:
CNXC traded an average of 971.99K shares per day over the past three months and 868930 shares per day over the past ten days. A total of 61.74M shares are outstanding, with a floating share count of 43.53M. Insiders hold about 30.08% of the company’s shares, while institutions hold 85.00% stake in the company. Shares short for CNXC as of 1767139200 were 8336861 with a Short Ratio of 8.58, compared to 1764288000 on 8108261. Therefore, it implies a Short% of Shares Outstanding of 8336861 and a Short% of Float of 16.149999.
Earnings Estimates
. The current rating of Concentrix Corp (CNXC) is the result of assessments by 2.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $2.87, with high estimates of $2.94 and low estimates of $2.79.
Analysts are recommending an EPS of between $13.04 and $11.93 for the fiscal current year, implying an average EPS of $12.26. EPS for the following year is $13.94, with 2.0 analysts recommending between $14.03 and $13.84.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 2 analysts. It ranges from a high estimate of $2.5B to a low estimate of $2.49B. As of. The current estimate, Concentrix Corp’s year-ago sales were $2.37BFor the next quarter, 2 analysts are estimating revenue of $2.47B. There is a high estimate of $2.48B for the next quarter, whereas the lowest estimate is $2.47B.
A total of 5 analysts have provided revenue estimates for CNXC’s current fiscal year. The highest revenue estimate was $10.28B, while the lowest revenue estimate was $10.02B, resulting in an average revenue estimate of $10.12B. In the same quarter a year ago, actual revenue was $9.83BBased on 2 analysts’ estimates, the company’s revenue will be $10.5B in the next fiscal year. The high estimate is $10.53B and the low estimate is $10.46B.
